Keith McGahan has served as our Chief Legal Officer since June 2018, as Corporate Secretary since February 2018 and as Executive Vice President since June 2019. From August 2016 to June 2018, he served as Vice President, Chief Compliance Officer and Associate General Counsel. He brings to Spectrum more than 20 years of diverse experience in the healthcare, medical device and pharmaceutical industries. From 2015 through August 2016, Mr. McGahan served as Executive Director and Associate General Counsel at Avanir Pharmaceuticals. During his tenure at Avanir, Mr. McGahan served as legal advisor on all compliance and commercial related matters. From 2012 through 2015, Mr. McGahan served as Director, Healthcare Compliance at Johnson & Johnson, where he was responsible for executing the global compliance program. Prior to that, from 2003 through 2011, Mr. McGahan served as the Assistant Staff Judge Advocate to the Navy Surgeon General, Staff Judge Advocate to the Navy Medical Research Command as well as Staff Judge Advocate and Chief Compliance Officer at Naval Hospital Camp Pendleton.
Mr. McGahan is a Certified Compliance and Ethics Professional (CCEP) and holds a professional certificate in health care compliance & privacy from Seton Hall University, a Six Sigma Black Belt certification from Villanova University and is certified by UCLA’s Anderson School of Business as an accredited public company director.
Mr. McGahan holds a bachelor’s degree in Zoology from Connecticut College, a master’s degree in Business Administration from Pepperdine University, a Juris Doctorate from Seattle University School of Law and a Master of Laws in Taxation from University of San Diego School of Law.
What is Keith M. Mcgahan's net worth?
The estimated net worth of Keith M. Mcgahan is at least $223,017.66 as of March 14th, 2023. Mr. Mcgahan owns 216,522 shares of Spectrum Pharmaceuticals stock worth more than $223,018 as of April 19th. This net worth estimate does not reflect any other assets that Mr. Mcgahan may own. Learn More about Keith M. Mcgahan's net worth.
How do I contact Keith M. Mcgahan?
Has Keith M. Mcgahan been buying or selling shares of Spectrum Pharmaceuticals?
Keith M. Mcgahan has not been actively trading shares of Spectrum Pharmaceuticals within the last three months. Most recently, Keith M. Mcgahan sold 15,733 shares of the business's stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $0.82, for a transaction totalling $12,901.06. Following the completion of the sale, the insider now directly owns 216,522 shares of the company's stock, valued at $177,548.04. Learn More on Keith M. Mcgahan's trading history.
Who are Spectrum Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Spectrum Pharmaceuticals?
During the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 32,387 shares worth more than $35,625.70. The most recent insider tranaction occured on May, 26th when CFO Nora Brennan sold 32,387 shares worth more than $35,625.70. Insiders at Spectrum Pharmaceuticals own 2.7% of the company.
Learn More about insider trades at Spectrum Pharmaceuticals. Information on this page was last updated on 5/26/2023.
